Skip to main content
OpenTrials
Completed

NCT Number: NCT06941311

Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk

The investigators are modifying and testing the preliminary effectiveness and implementation of the combination of two psychosocial interventions, Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and the computer-assisted version of the Youth-Nominated Support Team (eYST). This registration will be for Aim 2 and a pilot randomized clinical trial for Aim 3 will be registered separately.

In this phase of the study, CBT-SP+eYST will be tested in an initial open trial (number of youth=6) to examine its feasibility and acceptability. Investigators will recruit Black adolescents that come to an urban emergency department (ED) for suicidal thoughts and/or behaviors to receive the intervention in an outpatient community mental health agency. The study focuses on the acute phase of CBT-SP, which is 12 sessions. Participants will nominate up to 4 caring adults in the participants lives to serve as support persons. These support persons will attend an education/orientation session to learn more about their role and how to support the youth.

Youth will be assessed at baseline, 6 weeks, and 14 weeks. Parents will be assessed at baseline and 14 weeks. Support persons will be assessed at baseline and 14 weeks. Fidelity assessments will be completed by clinicians after each CBT-SP session, after the YST psycho-ed session, and weekly to document contact with the support team.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Suicide Prevention Behavior Behavioral Symptoms Self-Injurious Behavior Suicide

Age range

12 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital of Michigan (CHM) Emergency Department, Detroit, Michigan, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for youth:

  • Patients of any gender between the ages of 12 and 17 years
  • Patients that are able to provide at least one verifiable contact for emergency or tracking purposes
  • Eligible for care at MiSide
  • Present to the ED with suicide risk (per protocol)
  • Self-identify as Black (obtain from face sheet collected in triage)
  • Willing and able to complete enrollment procedures
  • Willing and able to provide signed and dated informed assent

Exclusion criteria

for youth:

  • Unable to be consented in English
  • Do not have a parent/legal guardian available to provide consent
  • Are not able to provide informed assent or to participate in the assessment due to significant agitation, psychosis, cognitive impairment, learning disability, or medical trauma
  • Actively engaged in specialty mental health treatment

Parent/Guardian Inclusion Criteria:

  • Adults 18 years old and older
  • The parent or legal guardian of a youth participating in Aim 2
  • Understand written and spoken English
  • Willing and able to complete enrollment procedures
  • Willing and able to provide signed and dated informed consent

Parent/Guardian Exclusion Criteria:

  • Do not understand written and spoken English

Support Person Inclusion Criteria:

  • Adults 18 years and older
  • Understand written and spoken English
  • Approved to serve as a support person by the parent/legal guardian

Support Person Exclusion Criteria:

  • Do not understand written and spoken English
  • Not approved to serve as a support person by the parent/guardian

Treatment and study plan

Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP)

Behavioral

Clinicians will provide this specialized evidence-based mental health care. The study focuses on the acute phase of CBT-SP, which is 12 sessions. CBT-SP's goals are to reduce suicide risk factors, enhance coping, and prevent future suicidal behavior. Identifying the emotional, cognitive, behavioral, or familial processes that precede a suicide crisis is a major focus, which yields an individualized treatment plan. Each session lasts one hour and can be completed either in person or via a secure telehealth platform. Most youths will attend sessions on a weekly basis and therapists typically like to be in contact with parents as well.

Youth-Nominated Support Team

Behavioral

Youth will nominate up to 4 trusted adults. Following parental approval, Support Persons will attend an orientation session with their assigned intervention specialist, learn about the youth's difficulties, treatment plan, and receive ideas for supporting the youth. Support Persons will be asked to have contact with the youth each week for up to three months to offer emotional support, encourage participation in treatment, and support the youth's healthy behaviors. Support Persons will have weekly check-ins with their intervention specialist every week for the 3 months of the study. During these calls, Support Persons have an opportunity to discuss any questions or concerns they may have about the youth and how best to support them.

Primary outcomes

  1. Acceptability - percent of eligible youth consented

    Time frame: Baseline

    The intervention will be considered acceptable if at least 50% of eligible youth choose to enroll in the study.

  2. Feasibility - Mean number of support people

    Time frame: 6 weeks

    The intervention will be considered feasible if the mean number of support people per youth is at least 3.

  3. Acceptability - Mean number of support person contacts

    Time frame: 14 weeks

    The intervention will be considered acceptable if the mean number of support person contacts with youth is at least 7.

  4. Feasibility - Number of CBT-SP sessions attended

    Time frame: 14 weeks

    Number of CBT-SP sessions attended by youth

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • Children's Hospital of Michigan
  • MiSide
  • National Institute of Mental Health (NIMH)

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 23, 2025
Registry last updated
May 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.